YAZEN JOUDEH: Open Payments
NPI 1134301773 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122,299 in 315 payments from 33 companies in 2025. Trend: 2023 $50,312 · 2024 $104,897 · 2025 $122,299
Speaker / faculty: $94,222Consulting: $15,813Travel & lodging: $6,894Food & beverage: $5,300Education: $70
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 121 | $73,042 |
| Novo Nordisk Inc | 33 | $19,609 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $13,852 |
| PFIZER INC. | 23 | $9,458 |
| Eli Lilly and Company | 4 | $3,738 |
| AstraZeneca Pharmaceuticals LP | 24 | $532 |
| Phathom Pharmaceuticals, Inc. | 9 | $245 |
| ABBVIE INC. | 14 | $222 |
| Axsome Therapeutics, Inc. | 8 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $157 |
Products named: ZEPBOUND, Wegovy, CAPLYTA, NURTEC ODT, FARXIGA, VOQUEZNA, MOUNJARO, Kerendia.
Industry payments across IL — which companies pay providers there.
